BridgeMD
Long Term Outcomes
EU CTIS ID: 2023-505098-34-00
What this study is testing
Assess the clinical outcomes of long-term treatment with SUBLOCADE in participants with a history of having, or who currently have, moderate-to-severe OUD (US and Canada) or opioid dependence (Australia and EU)
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Is an adult ≥ 18 years of age who has signed the ICF
- Plans to receive additional SUBLOCADE injections and has initiated treatment for OUD/opioid dependence with SUBLOCADE within the last 3 months prior to Baseline Visit OR has completed an Indivior SUBLOCADE study (eg, INDV-6000-401, INDV-6000-405) and has received the last dose of SUBLOCADE on that study within 3 months prior to Baseline Visit
You likely can't join if
- Patient participating in any clinical trial requiring medical intervention
- Patient currently using opioids to treat a diagnosis other than OUD/opioid dependence
The study team makes the final eligibility decision.
Where it's taking place
- Australia
- Canada
- United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Australia; Canada; United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.